Press release -
Novus Scientific Announces TIGR® Matrix Surgical Mesh Distribution Agreements in Major European Markets.
Steve Chaplin, Managing Director of Pulse Surgical Ltd in the United Kingdom said: “Pulse Surgical are delighted to be working with Novus within the UK market, where their products should perfectly complement our existing focus on promoting innovative, quality devices in the surgical arena for enhanced clinical outcomes and cost benefits to the healthcare providers.”
Covering the Italian market, AMS s.a (Advanced Medical Supplies) Managing Director Sergio Marazzi said: ”The people of AMS are looking forward to a successful collaboration with Novus Scientific and to being able to present TIGR® Matrix Surgical Mesh to Italian surgeons. This innovative product fits perfectly into our portfolio and strengthens our pledge of bringing excellent patient care products to our customers.”
TIGR® Matrix Surgical Mesh is the world’s 1st long-term resorbable,100% absorbable synthetic mesh indicated for reinforcement of soft tissue where weakness exists. Its unique patented dual-fiber construction is designed for gradually increasing mechanical compliance, making it strong for 6 months and gone in 3 years. The US Food and Drug Administration (FDA) gave the company 510(k) clearance to market TIGR® Matrix Surgical Mesh In January 2010. In August 2011 Novus Scientific received CE Mark approval from BSI for TIGR® Matrix Surgical Mesh in Europe.
CONTACT: Tom Haeleydt – Responsible for Business Development – EMEA · Email Tom Haeleydt (tom.haeleydt@novusscientific.com)
Visit our PRESSROOM: http://www.mynewsdesk.com/pressroom/novus-scientific
Topics
- Health, Health Care, Pharmaceuticals
Categories
- novus scientific
- surgical mesh
- resorbable
- matrix
- absorbable
- tigr matrix
About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable (100% absorbable) synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden. The company’s roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world’s foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® Matrix Surgical Mesh throughout the United States.
TIGR® Matrix - The world’s 1st long-term resorbable, 100% absorbable synthetic mesh with unique patented dual-fiber construction, designed for gradually increasing mechanical compliance.
TIGR® is a registered trademark of Novus Scientific Pte. Ltd
